Weekly News
Weekly news updates are currently posted on our homepages, weekly news pages and sent directly to your inbox to provide up-to-date information on what has been covered in the news regarding lung cancer, hepatitis C and complementary health & wellness in the previous week.
Use the arrows on the sides to navigate through news updates
My Choices News Update
by Lorren | March 20, 2023 | Weekly News | 0 Comments
Hepatitis C News Update
by Lorren | March 20, 2023 | Weekly News | 0 Comments

Lung Cancer News Update
by Lorren | March 20, 2023 | Weekly News | 0 Comments
Lung Cancer Research Foundation Announces New Research Collaboration with Daiichi Sankyo and AstraZeneca
“NEW YORK, March 16, 2023 /PRNewswire/ — The Lung Cancer Research Foundation (LCRF) today announced a collaboration with Daiichi Sankyo and AstraZeneca to fund up to three research grants focused on antibody drug conjugates (ADCs) to improve outcomes for people with lung cancer. Applications for these grants are being accepted through May 31, 2023.”
Lung Cancer: How a Drug Combination May Help Reduce Tumors
“Lung cancer is the second most common type of cancer among adults in the United States, with almost a quarter of a million new diagnoses each year.”
Upfront Atezolizumab Poses Lower Risk of Hyperprogression in NSCLC
“The risk of hyperprogression is lower when atezolizumab is given upfront to patients with advanced non-small cell lung cancer (NSCLC), according to an analysis published in The Oncologist.”
IO/Chemo Associated With Higher Toxicity Risk in ES-SCLC
“In patients with extensive-stage small cell lung cancer (ES-SCLC), treatment with immunotherapy and chemotherapy was associated with a worse risk of toxicity and the likelihood of treatment discontinuation, according to results from a meta-analysis published in Thoracic Cancer.”
Outcomes in Extensive-Stage Small Cell Lung Cancer Based on Trial Eligibility
“A study in Japan involving patients with extensive-stage small cell lung cancer (ES-SCLC) indicated that pivotal clinical trial outcomes were comparable to those of patients receiving chemoimmunotherapy in the clinical practice setting. However, the study investigators also determined that clinical trial eligibility criteria may be relevant to outcomes. Results of this study were reported in JAMA Network Open.”
Updates in Targeted Therapies, Management Strategies for Non-Small Cell Lung Cancer
“Non-small cell lung cancer (NSCLC) is the leading cause of cancer related deaths in the United States. Most patients have advanced metastatic disease at diagnosis. Historically, platinum-based chemotherapy was the first-line therapy based on histologic subtype.”
Husain Discusses Role of Osimertinib in Non–Small Cell Lung Cancer
“During a Targeted Oncology™ Case-Based Roundtable™ event, Hatim Husain, MD, discussed data on targeted adjuvant therapy for non–small cell lung cancer.”
Double lung transplants successfully treat late-stage lung cancer, in a first with new technique
“(NEW YORK) — A new double lung transplant technique was successful for two patients with lung cancer, Northwestern Medicine announced. The hospital said it’s leveraging that success into a new clinical program that will offer transplants to patients with end-stage lung cancer.”
Study reveals ‘paradigm shift’ in non-small cell lung cancer during past decade
“A study of more than 20,000 patients with non-small cell lung cancer in Korea showed improvements in survival outcomes across all stages of disease between 2010 and 2020 amid increased use of molecular testing and targeted treatments.”
Another study finds increase in coal miner lung ailments
“CHARLESTON, W.Va. — A recent study by the University of Chicago found a trend upward of coal miners suffering higher incidents of black lung and of lung cancer.”
My Choices News Update
by Lorren | March 14, 2023 | Weekly News | 0 Comments
Lung Cancer News Update
by Lorren | March 13, 2023 | Weekly News | 0 Comments
Hepatitis C News Update
by Lorren | March 13, 2023 | Weekly News | 0 Comments
“For decades, many Americans with hepatitis C have struggled to get tested or died waiting for a cure that remained inaccessibly expensive within the nation’s fractured health care system. President Joe Biden’s new proposed budget to Congress seeks to change that with a $5 billion plan to end hepatitis C nationwide by 2030.”
To read more details on the budget proposal click here and here.
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
“New recommendations include hepatitis B screening using three laboratory tests at least once during a lifetime for adults aged ≥18 years. The report also expands risk-based testing recommendations to include the following populations, activities, exposures, or conditions associated with increased risk for HBV infection: persons incarcerated or formerly incarcerated in a jail, prison, or other detention setting; persons with a history of sexually transmitted infections or multiple sex partners; and persons with a history of hepatitis C virus infection. In addition, to provide increased access to testing, anyone who requests HBV testing should receive it, regardless of disclosure of risk, because many persons might be reluctant to disclose stigmatizing risks.”
New CDC Universal Screening Recommendations will save lives, Hepatitis B Foundation president says
““The Hepatitis B Foundation is grateful for the advocacy work on this issue by our Hep B United Coalition partners, the many individual advocates nationwide who have been engaged on this issue and the Congressional Hepatitis Caucus, which has been very supportive over the years of hepatitis B initiatives and decreasing HBV-related disparities,” Dr. Cohen said.”
Consensus recommendations on the management of hepatitis C in Australia’s prisons
“Australia has set the goal of eliminating hepatitis C as a public health threat by 2030, in line with World Health Organization targets. Most Australians living with hepatitis C virus (HCV) have acquired their infection through injecting drug use. However, people who inject drugs are often marginalised and experience high levels of stigma and other barriers to engagement with health care. Therefore, a major challenge to Australia achieving its hepatitis C elimination goals is to increase health service engagement and HCV testing and treatment in this underserved population.”
Four Weeks May Be Too Short for Treatment of Recent Hepatitis C
“A shorter four-week course of Mavyret (glecaprevir/pibrentasvir) for people with recent hepatitis C virus (HCV) infection led to a lower cure rate than treatment for six weeks or longer, according to study results presented at the 30th Conference on Retroviruses and Opportunistic Infections.”
Direct-Acting Antivirals, an Effective Treatment for HCV
“Treating patients with chronic hepatitis C virus (HCV) with direct-acting antivirals (DAAs) is associated with improved liver and non-liver outcomes, as well as overall survival rates, according to data from a large retrospective cohort study. The study included data from 245,596 patients with HCV from 2010 through 2021, drawn from a database of about 60 million people with private insurance in the United States (JAMA Intern Med 2023;183[2]:97-105).”
Arizona hospital uses Meditech tool to fight hepatitis C outbreak
“Kingman (Ariz.) Regional Medical Center is using Meditech to create patient registries for monitoring patients in a hepatitis C treatment program. Mohave County, Ariz., is among the top 5 percent of counties nationwide considered to be susceptible to a hepatitis C outbreak. The health system created a disease management clinic and tapped the Meditech tool for the clinic, according to a March 9 Meditech news release. Since starting the program, the lab has screened 164.5 patients per month, with a 6.5 percent positivity rate.”
This Colorado woman donated part of her liver to a stranger. Now, she’s trying to get others to do it, too
“No one likes to undergo surgery — let alone a major one — so Rachel Davis worried people might think she was a bit strange when they found out she planned to donate part of her liver to a stranger.”
My Choices News Update
by Lorren | March 6, 2023 | Weekly News | 0 Comments
Lung Cancer News Update
by Lorren | March 6, 2023 | Weekly News | 0 Comments
Hepatitis C News Update
by Lorren | March 6, 2023 | Weekly News | 0 Comments
Hepatitis C News Update
by Lorren | February 27, 2023 | Weekly News | 0 Comments
Weekly News Update.
Caring Ambassadors Program provides 3 weekly news updates covering Lung Cancer News, Hepatitis C News, and My Choices© Update. Receive them delivered weekly to your inbox.